deepull, a Barcelona, Spain-based medical diagnostics firm, raised €50M in Collection C funding.
The spherical was led by Columbus Enterprise Companions, Panakès Companions, and Mérieux Fairness Companions with participation from current buyers Asabys Companions, Innvierte-CDTI, We Enterprise Capital, UI Investissement, Axis-ICO, Aliath Bioventures, and Kurma Companions.
The corporate intends to make use of the funds to finalize medical validation and expedite the regulatory approval technique of its UllCORE diagnostic system.
Led by CEO Jordi Carrera, deepull is a medical diagnostics firm creating culture-free diagnostic options for sepsis and acute infections. It’s creating the UllCORE BSI Check, concentrating on 95% of sepsis-causing pathogens, an automatic, walkaway system, which makes use of molecular methods to extract and detect microbial DNA immediately from entire blood. The multiplex PCR take a look at covers 95% of sepsis-causing pathogens, together with micro organism and fungi, in addition to antibiotic resistance genes, offering crucial outcomes to caregivers in about one hour.
FinSMEs
30/04/2025
